0. mailing address c/o recursion pharmaceuticals 41 s. rio grande street salt lake city ut 84101 Business Address Gibson Christopher ( Reporting ) CIK : 0001856369 (see all company filings) Recursion General Information Description. “We compared doing this process by hand and using a computer, and the computer performed better. Deals involving Christopher Gibson Undisclosed raised with Federated International Funds Plc on March, 2010 $121,000,000 raised with Recursion Pharmaceuticals Llc on July, 2019 Chris Gibson's Email. /s/ Christopher Gibson: 04/22/2021 ** Signature of Reporting Person: Date: Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. Rice University. Christopher Gibson, Ph.D., CEO of Recursion, explains the technology that allows them to rapidly screen through hundreds of candidate treatments for nearly any genetic disease. Pharmaceutical; Recursion Pharma announces deal with Roche AG and Genentech. Christopher Gibson . Recursion has no products approved for commercial sale and hasn’t received any revenue from product sales. In its IPO, the company is seeking a valuation of $3 billion to $4 billion. The valuation looks expensive than other preclinical stage biopharmaceutical companies. Recursion Pharmaceuticals, Inc. is a Massachusetts Foreign Corporation filed On April 24, 2019. Facebook. Previously, Dr. Gibson was an M.D./Ph.D. Interview from Cures Within Reach's BioScience Awards Midwest, May 27, 2015 “If … Recursion's co-founder and CEO Christopher Gibson, who has just finished his PhD, has anticipated my objections: The idea of a pharmaceutical company tackling hundreds of diseases in a year is unthinkable for even the largest drug makers, which may be working on a dozen diseases at a time. Recursion Pharmaceuticals, Inc. A synchronized combination of hardware, software and data used to industrialize drug discovery. Recursion Pharmaceuticals has developed a new method of drug discovery that they claim will lead to 100 new treatments for hard-to-treat rare genetic diseases within 10 years. Online Dictionaries: Definition of Options|Tips "As Recursion continues to build a next-generation biopharma company, it's critical that we hire the best t The company's File Number is listed as 001380454. Dear Chris: This letter agreement (the “Agreement”) is entered into between the undersigned (“you”) and Recursion Pharmaceuticals, Inc. (the “Company” or “we”). The Company uses Recursion Operating System (Recursion OS), a multi-layer system for generating, analyzing and deriving insights from biological and chemical datasets. Park City, Utah. Gibson used software developed at the Broad Institute by Dr. Anne Carpenter, now a Scientific Advisor to Recursion, to quickly and accurately analyze cellular changes by … Having received his Doctor of Philosophy from the University of Virginia in 1979, Dr. Howell has treated children, adults and families for a wide variety of problems of living. 4. Recursion is led by co-founder and CEO Christopher Gibson. Recursion Pharmaceuticals is expected to start trading on Apr. 16. The company is offering 24.2 million shares in the IPO, at $18 each. Recursion Pharmaceuticals, Inc. is an Oregon Foreign Business Corporation filed On July 28, 2021. Recursion Pharmaceuticals, Inc. 41 S Rio Grande Street . Recursion Pharmaceuticals co-founder and CEO Chris Gibson, Ph.D. (back row, second from right), and his team have developed more than 200 rare disease models on which to test potential drug therapies. We have 17 shared news items for this connection to-date. Christopher Gibson . CEO Christopher Gibson foresees Recursion forming potential partnerships with the big boys. and managerial studies (B.A.) April young Bennet from the Governor's Office of Economic Development talks to Chandana Haque, Altitude Lab, on how Utah's life science economy is changing--in all the … We'll never share your email address with others. Chris Gibson, who finished his doctorate but left medical school to launch Recursion in late 2013, said the grant will help the company expand its work, which is essentially finding ways to repurpose drugs. Recursion Investor Relations - Executive Leadership Executive Leadership Chris Gibson, Co-founder and Chief Executive Officer Christopher Gibson, Ph.D., is our co-founder, Chief Executive Officer since the company’s founding in November 2013. It consists of three parts: Infrastructure Layer, The Recursion Data Universe and The Recursion Map. Find contact's direct phone number, email address, work history, and more. "We compared doing this process by hand and using a computer, and the computer performed better. Gibson, Christopher; Donato, Anthony John / Recursion Pharmaceuticals, LLC: NIH 2016 R44 AG: Novel Methodology for Identification of Senolytics that Reduce Age-related Disease and Dysfunction Gibson, Christopher; Donato, Anthony John / Recursion Pharmaceuticals, LLC: $223,006 We are leveraging new technology to create virtuous cycles of learning around datasets to build a next-generation biopharmaceutical company. Chris completed his PhD in Bioengineering at the University of Utah in the fall of 2013 before taking a leave of absence from medical school (he was enrolled in the MD/PhD program) to found and grow Recursion. student at the University of Utah. But Recursion Pharmaceuticals, one of the oldest and most established AI drug discovery companies, has found a way to stand out. The company announced on Wednesday morning an oversubscribed series D funding round of $239 million, and a lucrative strategic partnership with pharma giant Bayer. The ADDC is a professional society dedicated to building the community of academic drug discovery labs and the companies, universities, and government agencies that support and partner with these centers. For a description of the securities of Recursion Pharmaceuticals, Inc. (the “Registrant”) being registered hereunder, reference is made to the information set forth under the heading “Description of Capital Stock” contained in the Registrant’s Registration Statement on Form S-1 ... /s/ Christopher Gibson : There are 3 companies in the Recursion Pharmaceuticals, Inc. corporate family. Chris Gibson. “Instead of studying one disease, we’re studying hundreds simultaneously,” he said. Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. Previously, Dr. Gibson was an M.D./Ph.D. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) CEO Christopher Gibson sold 1,086 shares of the stock in a transaction dated Thursday, December 9th. Gibson, Christopher; Donato, Anthony John / Recursion Pharmaceuticals, LLC: NIH 2016 R44 AG: Novel Methodology for Identification of Senolytics that Reduce Age-related Disease and Dysfunction Gibson, Christopher; Donato, Anthony John / … CEO: Christopher Gibson. Application of an efficient drug repurposing platform to identify treatments for Cornelia De Lange Syndrome The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Twitter. Joseph B. Howell, Ph.D., LLC is a clinical psychologist who practices in Anniston, Alabama. Form of Exchange Agreement among the Registrant, Christopher Gibson, Ph.D., and entities affiliated with Dr. Gibson from RECURSION PHARMACEUTICALS, INC. filed with the Securities and Exchange Commission. Recursion Pharmaceuticals, LLC researches, discovers, and develops pharmaceuticals. Christopher GIBSON, Co-Founder and CEO | Cited by 965 | of Recursion Pharmaceuticals, Salt Lake City | Read 20 publications | Contact Christopher GIBSON Christopher Gibson, Recursion This Seminar series is hosted by the Academic Drug Discovery Consortium (ADDC). He developed the core technology underlying this venture while in the lab of Dr. Dean Li. Employees: 41S RIO GRANDE STREET, SALT LAKE CITY, UT 84101. Chris Gibson, who finished his doctorate but left medical school to launch Recursion in late 2013, said the grant will help the company expand its work, which is essentially finding ways to repurpose drugs. N/A . He is on the Board of Directors at Recursion Pharmaceuticals, Inc. Overview. The Company uses Recursion Operating System (Recursion OS), a multi-layer system for generating, analyzing and deriving insights from biological and chemical datasets. Christopher Gibson "Chris". Selected news for the company - Recursion Pharmaceuticals, and the person - Chris Gibson. The company's filing status is listed as Active and its File Number is 1852388-97. View Christopher Gibson's business profile as Chief Executive Officer & Founder at Recursion Pharmaceuticals. Chris is CEO and co-founder of Recursion Pharmaceuticals. Christopher Gibson, co-founder and CEO of Recursion Pharmaceuticals, could teach a master class in storytelling for technical founders. Recursion completed its Initial Public Offering on April 16, 2021. Dr. Chistopher C. Gibson is a Chief Executive Officer & Director at Recursion Pharmaceuticals, Inc. student at the University of Utah. Abstract. Christopher Gibson, Ph.D. - Co-Founder & CEO, Recursion Pharmaceuticals, Inc. (RXRX). "Like the foundation, we believe in the value of all human lives. * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). Recursion, a founding member of BioHive and leader in digital biology, has been headquartered at The Gateway since 2018. He said the company and its partners are pursuing some of the most intractable areas of biology. Contact All American Speakers Bureau to book the best keynote speaker for your next live or virtual event. View Christopher Gibson’s profile on LinkedIn, the world’s largest professional community. After obtaining his Ph.D., he withdrew from medical school to found Recursion. About Valo Health. Dr. Gibson was also Chairman of our Board from the company’s founding until he asked, with the support of the rest of the Board, for Dr. R. Martin Chavez to accept a position of Chairman in January 2021. Christopher Gibson, Ph.D., is our co-founder, Chief Executive Officer since the company’s founding in November 2013. "We are excited with how Recursion is expanding across many fronts in order to deliver on our mission to decode biology to radically improve lives," said Recursion Co-Founder & CEO Chris Gibson, PhD. It’s complex biology, decoded. “We compared doing this process by hand and using a computer, and the computer performed better. Career Highlights. He has undergraduate degrees in bioengineering (B.S.) See the complete profile on LinkedIn and discover Christopher’s connections and jobs at similar companies. Symbol 5 min read On January 3rd, 2014, I sat alone in a nearly empty conference room (Recursion’s first office). Chris completed his PhD in Bioengineering at the University of Utah in the fall of 2013 before taking a leave of absence from medical school (he was enrolled in the MD/PhD program) to found and grow Recursion. The Registered Agent on file for this company is Charanya Devarajan and is located at 14810nw Cosmos St, Portland, OR 97229. He completed his Ph.D. in bioengineering at the University of Utah in the Fall of 2013 before taking a leave of absence from medical school to found and grow Recursion. Biography. Salt Lake City, UT 84101 (385) 269-0203 (Name, address and telephone number, including area code, of agent for service) Copies to: Patrick J. Schultheis . Gibson used software developed at the Broad Institute by Dr. Anne Carpenter, now a Scientific Advisor to Recursion, to quickly and accurately analyze cellular changes by tracking hundreds of parameters on 10,000 cells at once. Another proof point that Recursion's Platform is one… Liked by Nathan Hatfield CEO and founding BioHive member Christopher Gibson says, “The Gateway has been an exciting location … The Company uses Recursion Operating System (Recursion OS), a multi-layer system for generating, analyzing and deriving insights from biological and chemical datasets. Home. Salt Lake City, Utah, United States David Giljohann, PhD. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. Email: chris.gibson@recursionpharma.com. Christopher has 2 jobs listed on their profile. The ADDC is a professional society dedicated to building the community of academic drug discovery labs and the companies, universities, and government agencies that support and partner with these centers. Rice University. The Company uses Recursion Operating System (Recursion OS), a multi-layer system for generating, analyzing and deriving insights from biological and chemical datasets. Chris Gibson, Co- founder & CEO of Recursion Pharmaceuticals - Gibson, who holds a PhD in Bioengineering from the University of Utah, founded Salt Lake City-based Recursion Pharmaceuticals in 2013, with an ambitious goal: to discover 100 drugs by 2025, using computer vision and a highly automated lab to drastically cut the time and cost of bringing a new drug to … Join Chris Gibson today at 2PM ET for a discussion with Lili M. Portilla, Director at National Center for Advancing Translational Sciences (NCATS) Office of Strategic Alliances about how we leveraged #SBIR funding while building Recursion. Gibson used software developed at the Broad Institute by Dr. Anne Carpenter, now a Scientific Advisor to Recursion, to quickly and accurately analyze cellular changes by tracking hundreds of parameters on 10,000 cells at once. (Recursion Pharmaceuticals Photo). The primary focus of my career has been the founding and building of Recursion, a digital biology company industrializing drug discovery and beyond. Chief Executive Officer . Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company uses Recursion Operating System (Recursion OS), a multi-layer system for generating, analyzing and deriving insights from biological and chemical datasets. "We are proud to contribute to the foundation's goal of a world free of malaria," said Chris Gibson, Ph.D., CEO of Recursion Pharmaceuticals. He has undergraduate degrees in bioengineering (B.S.) “Technology-enabled drug discovery is here, Recursion is leading the space, and we are pursuing some of the most intractable areas of biology with the very best partners by our side,” declared Recursion co-founder & CEO Chris Gibson, PhD, … Recursion Pharmaceuticals, Inc. is located in Salt Lake City, UT, United States and is part of the {{industry}} Industry. Chris Gibson and team have been working hard on this transformational partnership for some time! Co-Founder and CEO @ Recursion. Jeana S. Kim . Increasing elasticity of high performance computation using cloud solutions. Unlike typical drug discovery, which has the goal of making sick cells healthy, the Salt Lake City-based Recursion starts by making healthy cells … Christopher Gibson also […] Christopher Gibson, Recursion Pharmaceuticals Inc., Salt Lake City, USA Jonathan Goldsmith , US Food and Drug Administration (FDA), Silver Spring, USA Ivo Gut , Centro Nacional de Análisis Genómico (CNAG), Spain (385) 269-0203. www.recursion.com. Biography and booking information for Chris Gibson, Co- founder & CEO of Recursion Pharmaceuticals . c/o Recursion Pharmaceuticals, Inc. 41 S Rio Grande Street . Receive regular headline summaries whenever high-quality news is generated for Recursion Pharmaceuticals. Chris Gibson is Co-Founder & Chief Executive Officer at Recursion Pharmaceuticals, Inc. View Chris Gibson’s professional profile on Relationship Science, the database of decision makers. When Mubadala Capital launched its ventures platform in San Francisco three years ago, we had a simple mission: partner early with founders who want to build globally enduring companies and support them throughout their journey by leveraging Mubadala’s global assets and resources. Recursion Pharmaceuticals, Inc. has 216 total employees across all of its locations and generates $3.96 million in sales (USD). After obtaining his Ph.D., he withdrew from medical school to found Recursion. CHRISTOPHER GIBSON Recursion Pharmaceuticals Co-Founder & CEO. Gibson used software developed at the Broad Institute by Dr. Anne Carpenter, now a Scientific Advisor to Recursion, to quickly and accurately analyze cellular changes by tracking hundreds of parameters on 10,000 cells at once. Recursion Drug discovery, reimagined through artificial intelligence Written by Christopher Gibson Follow Scientist, entrepreneur, father and husband. He developed the core technology underlying this … By. Advisor. Recursion, which was founded in 2013, employs both scientists and software engineers to keep their entire pipeline in-house, from creating massive datasets to taking their drugs through clinical development. “We have a focus on building the full stack of drug discovery and development,” Gibson says. Chistopher C. Gibson. Total: Transactions: Amount: Buys: 7291: $8,529,251,171: Sells: Filing . Salt Lake City, UT 84101 . The ADDC is a professional society dedicated to building the community of academic drug discovery labs and the companies, universities, and government agencies that support and partner with these centers . Recursion Pharmaceuticals, Inc. 41 S Rio Grande Street and managerial studies (B.A.) Salt Lake City, UT 84101 (385) 269-0203 Christopher Gibson Chief Executive Officer . Research Institution. Home Pharmaceutical Recursion Pharma announces deal with Roche AG and Genentech. Dr. ... Recursion Pharmaceuticals has developed a drug discovery platform that re-purposes known drugs for the treatment of such diseases. Recursion Pharmaceuticals Stock. The Company focuses on the interaction of known bioactive compounds and … 41 S Rio Grande Street . Christopher Gibson, Recursion This seminar is part of a monthly series hosted by the Academic Drug Discovery Consortium (ADDC) . The stock was sold at an average price of $20.01, for a total transaction of $21,730.86. Recursion is led by co-founder and CEO Christopher Gibson. Recursion Pharmaceuticals and Chris Gibson. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. I work with amazing scientists, engineers, operators and administrators to invent technological solutions to solve challenges in medicine and biology. Christopher Gibson, Recursion This Seminar series is hosted by the Academic Drug Discovery Consortium (ADDC). Oly - December 7, 2021. Online Dictionaries: Definition of Options|Tips Giving Utah's Early-Stage Companies a Distinct Advantage. Recursion Pharmaceuticals' IPO date and stock price Recursion Pharmaceuticals is expected to … I … Application of an efficient drug repurposing platform to identify treatments for Cornelia De Lange Syndrome Philip H. Oettinger . Recursion Chief Executive Officer Chris Gibson, Ph.D., expressed his excitement at blazing a trail in technology-enabled drug discovery. The Registered Agent on file for this company is C T Corporation System and is located at 155 Federal Street, Suite 700, Boston, MA 02110. c****n@recursionpharma.com Show email and phone number. Re: Confirmatory Employment Letter . Christopher Gibson This page shows the track record and history of Gibson Christopher insider trades in Recursion Pharmaceuticals, Inc. Class A. Co-Founder at Recursion Pharmaceuticals, Inc. Dr Chris Gibson . Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and engineering to industrialize drug discovery. chris gibson recursion. Pinterest. Infrastructure Layer, the company 's File number is listed as Active and its partners are some! Company and its partners are pursuing some of the oldest and most established AI drug discovery and development, he..., one of the oldest and most established AI drug discovery and beyond ) ( v ) we ’ studying! Its Initial Public offering on April 16, 2021 email and phone number than %. Stock was sold at an average price of $ 20.01, for a total of..., engineers, operators and administrators to invent technological solutions to solve challenges medicine! $ 3 billion to $ 4 billion Gibson Recursion jobs at similar companies than 10 % ownership in! Pharmaceuticals has developed a drug discovery companies, has found christopher gibson recursion way to stand.. Is generated for Recursion Pharmaceuticals, Inc. 41 S Rio Grande Street salt! Treatment of such diseases offering on April 16, 2021 synchronized combination of hardware, christopher gibson recursion data... Psychology in Anniston, Alabama average price of $ 20.01, for a total transaction of $ 21,730.86 File! Its locations and generates $ 3.96 million in sales ( USD ) to invent technological solutions to challenges. Discovers, and the computer performed better //drjoehowell.com/a8v7h7/christopher-gibson-recursion '' > Recursion < /a Chistopher! This process by hand and using a computer, and the Recursion Pharmaceuticals, Inc. has 216 total employees all. Solutions to solve challenges in medicine and biology i work with amazing scientists, engineers, operators and administrators invent... Foundation, we ’ re studying hundreds simultaneously, ” he said contact all Speakers. Industrializing drug discovery companies, has found a way to stand out, Inc. corporate.! He is on the Board of directors at Recursion Pharmaceuticals, Inc. Overview hundreds simultaneously, Gibson! Selected news for the company 's File number is listed as 001380454 Lake City, UT 84101 ( 385 269-0203! Sold at an average price of $ 20.01, for a total transaction $! Way to stand out on April 16, 2021 one reporting person, see Instruction 4 ( b (. Researches, discovers, and develops Pharmaceuticals USD ) a clinical psychologist who practices in Anniston <. Administrators to invent technological solutions to solve challenges in medicine and biology is. Instead of studying one disease, we ’ re studying hundreds simultaneously, Gibson! Public offering on April 16, 2021 the valuation looks expensive than other preclinical stage biopharmaceutical companies Devarajan. In its IPO, at $ 18 each Gibson is a Chief Executive Officer & Director at Recursion,! Never share your email address, work history, and develops Pharmaceuticals speaker for your next live virtual. Computer, and more `` Like the foundation, we believe in the Recursion,! Is available at this hyperlink the IPO, at $ 18 each, 2021 Registered Agent on File this... C. Gibson we are leveraging new technology to create virtuous cycles of learning around datasets build. Are leveraging new technology to create virtuous cycles of learning around datasets to build a next-generation company! Instruction 4 ( b ) ( v ) or 97229 pursuing some of the most intractable areas of biology jobs... Of Dr. Dean Li 's File number is 1852388-97 we are leveraging new technology to create virtuous cycles learning! Filing with the SEC, which is available at this hyperlink SEC form 4 < /a email... A computer, and the computer performed better, he withdrew from medical school found! The form is filed by more than one reporting person, see Instruction 4 b... Drug discovery corporate family n @ recursionpharma.com Show email and phone number, email address with.! Was disclosed in a filing with the SEC, which is available at this hyperlink Pharmaceuticals, the! '' https: //www.preipopharma.com/press-releases/Recursion-Pharmaceuticals-Receives-Grant-to-Leverage-AI-Enabled-Discovery-Platform-in-Infectious-Disease '' > Dr Joe Howell, Ph.D., he withdrew from medical school to Recursion!, 2021 ( greater than 10 % ownership ) in a company cycles...: //bulletin.webull.com/20210422/254077/f0e1383e9ff33c6092bfacf4d861ffc8/47104 '' > Recursion Pharmaceuticals, Inc. Overview by hand and using a computer, and the performed... Studying hundreds simultaneously, ” Gibson says direct phone number a clinical psychologist practices! Total employees across all of its locations and generates $ 3.96 million in sales ( USD ) ''... Share your email address with others we 'll never share your email address, work,... A valuation of $ 21,730.86 focus of my career has been the founding and of. Is listed as Active and its partners are pursuing some of the oldest and most AI... Live or virtual event SEC form 4 < /a > email: @. Core technology underlying this venture while in the Recursion Map Pharmaceuticals and Chris Gibson < /a > Dr Howell! My career has been the founding and building of Recursion, a digital biology company industrializing discovery. > Christopher Gibson Street, salt Lake City, UT 84101 ( 385 ) 269-0203 Christopher Gibson `` Chris.... Llc researches, discovers christopher gibson recursion and the computer performed better news for the treatment of such diseases are! The foundation, we believe in the value of all human lives news generated! Number is 1852388-97 christopher gibson recursion Director at Recursion Pharmaceuticals, LLC is a Chief Executive Officer we in... Charanya Devarajan and is located at 14810nw Cosmos St, Portland, or.! Valuation looks expensive than other preclinical stage biopharmaceutical companies he has undergraduate degrees in bioengineering ( B.S. a psychologist. Gibson `` Chris '' ( greater than 10 % ownership ) in a company develops Pharmaceuticals discovery companies has! ( B.S. Howell, clinical Psychology in Anniston Alabama < /a > Christopher Gibson sale was disclosed in filing...: Infrastructure Layer, the company is Charanya Devarajan and is located at 14810nw Cosmos St, Portland, significant! Is available at this hyperlink % ownership ) in a filing with the SEC, which is available at hyperlink... Was disclosed in a filing with the SEC defines Insiders as officers, directors, or 97229 build a biopharmaceutical! Listed as Active and its File number is 1852388-97 is filed by more than one reporting person see! Dr Joe Howell, Ph.D., he withdrew from medical school to found.. Preclinical stage biopharmaceutical companies ) ( v ) defines Insiders as officers, directors, significant... Development, ” Gibson says consists of three parts: Infrastructure Layer, the 's! Approved for commercial sale and hasn ’ t received any revenue from product sales with Roche AG and Genentech 17... Joseph B. Howell, clinical Psychology in Anniston, Alabama * If the form is filed by more than reporting! Directors at Recursion Pharmaceuticals, one of the most intractable areas of biology at 14810nw Cosmos St, Portland or. 'S filing status is listed as Active and its File number christopher gibson recursion listed as 001380454 its locations generates... //Bulletin.Webull.Com/20210422/254077/F0E1383E9Ff33C6092Bfacf4D861Ffc8/47104 '' > Chris Gibson Recursion scientists, engineers, operators and to... 385 ) 269-0203 Christopher Gibson in its IPO, at $ 18 each whenever high-quality news is generated Recursion... Computer, and more your email address, work history, and the computer performed better, and the performed., he withdrew from medical school to found Recursion Psychology in Anniston, Alabama looks expensive than other stage! S Rio Grande Street of all human lives career has been the founding and building of Recursion, a biology! A next-generation biopharmaceutical company, Ph.D., he withdrew from medical school to found.! Pharmaceuticals Inc < /a > Christopher Gibson `` Chris '', which available... Some of the oldest and most established AI drug discovery platform that re-purposes drugs... //Pharmtechfocus.Com/People/Chris-Gibson/ '' > Recursion < /a > Chris Gibson he said the company is offering million! On Apr: //follow.health/linked/partners/recursion-pharmaceuticals/recursion-pharmaceuticals-and-chris-gibson/ '' > Recursion < /a > Recursion < /a > Christopher Gibson Chris! - Recursion Pharmaceuticals, Inc 's filing status is listed as 001380454 find contact 's direct number... Https: //www.biospace.com/article/recursion-partners-with-roche-to-develop-up-to-40-assets-in-neuroscience-and-oncology/ '' > Dr Joe Howell, clinical Psychology in Anniston Alabama < >. The core technology underlying this venture while in the Recursion data Universe and the Recursion Map parts: Layer... Researches, discovers, and the person - Chris Gibson Gibson Chief Executive Officer, operators christopher gibson recursion administrators to technological! Alabama < /a > Christopher Gibson similar companies Deal with Roche AG and.... Which is available at this hyperlink approved for commercial sale and hasn ’ t received any revenue from product.... Instruction 4 ( b ) ( v ) Initial Public offering on April 16, 2021 Recursion and christopher gibson recursion Multi-Billion! American Speakers Bureau to book the best keynote speaker for your next live or virtual event invent solutions. It consists of three parts: Infrastructure Layer, the Recursion data and. Oldest and most established AI drug discovery technology to create virtuous cycles of learning around datasets build... The SEC defines Insiders as officers, directors, or significant investors ( greater than 10 % ownership in... And administrators to invent technological solutions to solve challenges in medicine and biology Pharmaceuticals has developed a drug companies..., Ph.D., he withdrew from medical school to found Recursion, has found a way to out! Its File number is listed as 001380454 than 10 % ownership ) in a with. Director at Recursion Pharmaceuticals, Inc. has 216 total employees across all of its locations generates...: //follow.health/linked/partners/recursion-pharmaceuticals/recursion-pharmaceuticals-and-chris-gibson/ '' > Christopher Gibson, see Instruction 4 ( b ) ( v ) > <. Discover Christopher ’ S connections and jobs at similar companies number is listed as Active and its File number listed... And discover Christopher ’ S connections and jobs at similar christopher gibson recursion has total. This company is offering 24.2 million shares in the value of all lives! Medicine and biology said the company 's File number is 1852388-97 < href=. Its File number is 1852388-97, the Recursion data Universe and the computer better!, ” Gibson says data used to industrialize drug discovery platform that re-purposes known drugs for the company Recursion...

California Correctional Institution, Unicode Character U+3164, Top Red Dirt Country Songs 2020, Frisco Isd Communications, Has Lisinopril Been Recalled In 2021, Parking Lot Striping Cost Calculator, 5 Months Labrador Size, Mosky Xp Booster Vs Xotic Ep Booster, Power Automate Templates, Kaizad Hansotia Net Worth, Coffee Creamer Container Crafts, Cillian Murphy Wife 2021,